Read More Pharma Industry News Novartis to acquire AveXis for $8.7bn to expand gene therapy and neuroscience portfolio Novartis, a Swiss pharmaceutical giant, has confirmed a substantial acquisition of AveXis, a US-based gene therapy company, for… bySrinathApril 9, 2018
